NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10836	Companies
235277	Keywords
164215	Articles
126032	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 11/13/2025 at 22:15, 9 months 1 day ago

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
Nanobiotix announces advancements in Curadigm Nanoprimer platform with new patent applications, pre-clinical data, and external collaborations, aiming to revolutionize drug delivery

Pre-clinical Data Patent Applications NANOBIOTIX Curadigm Nanoprimer External Collaborations
BRIEF

published on 11/11/2025 at 22:20, 9 months 3 days ago

Nanobiotix participera à la conférence Jefferies London Healthcare

Biotechnologie Oncologie NANOBIOTIX Conférence Jefferies Nanoparticules
BRIEF

published on 11/11/2025 at 22:20, 9 months 3 days ago

Nanobiotix will participate in the Jefferies London Healthcare conference

Biotechnology Oncology NANOBIOTIX Nanoparticles Jefferies Conference
PRESS RELEASE

published on 11/11/2025 at 22:15, 9 months 3 days ago

NANOBIOTIX participera à la conférence Jefferies London Healthcare
Nanobiotix participera \u00E0 la conf\u00E9rence Jefferies London Healthcare le 17 novembre 2025. Pr\u00E9sentation en direct avec Laurent Levy et Bart van Rhijn

Biotechnologie Cancer Jefferies NANOBIOTIX Conf\u00E9rence
PRESS RELEASE

published on 11/11/2025 at 22:15, 9 months 3 days ago

NANOBIOTIX to Participate in Jefferies London Healthcare Conference
Nanobiotix to participate in Jefferies London Healthcare Conference on Nov 17, 2025, with company management as presenters. Webcast available. Learn about Nanobiotix and its disruptive therapeutic approaches

Webcast Nanotechnology NANOBIOTIX Therapeutic Approaches Jefferies London Healthcare Conference
BRIEF

published on 10/31/2025 at 08:05, 9 months 15 days ago

Nanobiotix Secures $71 Million Agreement with HealthCare Royalty

Long-term Growth HealthCare Royalty NANOBIOTIX Royalty Agreement Oncology Development
BRIEF

published on 10/31/2025 at 08:05, 9 months 15 days ago

Nanobiotix conclut un accord de 71 millions de dollars avec HealthCare Royalty

Croissance À Long Terme NANOBIOTIX Développement En Oncologie Contrat De Redevances Les Redevances Des Soins De Santé
PRESS RELEASE

published on 10/31/2025 at 08:00, 9 months 15 days ago

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
Nanobiotix announces $71M strategic royalty monetization agreement with Healthcare Royalty, extending cash runway and enabling long-term growth in cancer treatment

Cancer Treatment HealthCare Royalty Financial Agreement NANOBIOTIX Royalty Monetization
PRESS RELEASE

published on 10/31/2025 at 08:00, 9 months 15 days ago

NANOBIOTIX annonce un accord stratégique avec HealthCare Royalty pour un montant maximum de 71 millions de dollars et prolonge ainsi son horizon de trésorerie pour une croissance durable
Nanobiotix annonce un accord stratégique de 71 millions de dollars avec HealthCare Royalty pour étendre son horizon de trésorerie et soutenir la croissance à long terme

Croissance Financement Accord Stratégique HealthCare Royalty NANOBIOTIX
BRIEF

published on 10/01/2025 at 22:20, 10 months 13 days ago

NANOBIOTIX révèle des résultats prometteurs d'une étude de phase 1 pour le traitement du cancer de l'œsophage

Étude De Phase 1 Radiothérapie JNJ-1900 (NBTXR3) Cancer De L'œsophage Événements Indésirables

Accesswire

Published on 08/15/2026 at 00:50, 16 hours 58 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 17 hours 33 minutes ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 18 hours 3 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 18 hours 23 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 18 hours 48 minutes ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/15/2026 at 15:05, 2 hours 42 minutes ago

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 9 hours 42 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 23 hours 19 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:29, 23 hours 19 minutes ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 23 hours 33 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/13/2026 at 18:00, 1 day 23 hours ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 4 days ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 4 days ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 23 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 23 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE